U.S. markets closed
  • S&P 500

    +39.95 (+1.06%)
  • Dow 30

    +321.83 (+1.05%)
  • Nasdaq

    +99.11 (+0.90%)
  • Russell 2000

    +19.77 (+1.16%)
  • Crude Oil

    +2.65 (+2.51%)
  • Gold

    +0.90 (+0.05%)
  • Silver

    -0.54 (-2.66%)

    -0.0049 (-0.47%)
  • 10-Yr Bond

    -0.0830 (-2.79%)

    -0.0076 (-0.62%)

    -0.4670 (-0.34%)

    +532.28 (+2.80%)
  • CMC Crypto 200

    +1.99 (+0.47%)
  • FTSE 100

    -0.63 (-0.01%)
  • Nikkei 225

    -457.42 (-1.73%)

MDClone Launches the Only Synthetic Data Platform for Life Science RWE Project Collaboration

·4 min read

Connecting Life Science Organizations to the Most Innovative Health Systems Worldwide to Fundamentally Change Speed to Data Access and Data Security

BE'ER SHEVA, Israel, May 11, 2022--(BUSINESS WIRE)--MDClone, a digital health company and the leader in synthetic data, today announced the launch of The MDClone Connect Platform, an innovative workspace enabling cross-organizational collaboration with dynamic access to 50+ million synthetic patient records.

Uniting life sciences, tech companies, and other third-party organizations with leading health systems worldwide, the Connect Platform will allow users to securely and efficiently work together on projects that will streamline product development, improve operational and patient outcomes, and strengthen best practices to accelerate healthcare innovation together.

MDClone offers partners robust, detailed data for thorough end-to-end real-world analysis. Using MDClone’s existing ADAMS analytics tools and synthetic data capabilities, clinicians, researchers, and healthcare professionals can explore healthcare data efficiently to accelerate real-world evidence processes. With synthetic data capabilities at the forefront, users leverage self-service tools to access, analyze, and share information without privacy concerns.

"We built the Connect Platform to address the growing need to connect health systems with life science and other third-party organizations who are seeking faster approaches to discovery. These organizations require rich data and partners to develop, evaluate, and implement new findings. With the platform, we provide access to the full payload of EHR and clinical data repositories while protecting the privacy of patients and organizations above all else. As the industry leader in synthetic data, combined with our forward-thinking approaches to self-service data exploration, we offer a unique solution to get usable, granular data to power RWE projects in record time," explains MDClone’s Robi Wartenfeld, CMO, VP Product Strategy.

The Connect Platform is the underlying technology that enables a thriving collaborative called The Global Network, which provides more than 30 years of unmatched data granularity for project exploration and research expertise from more than 15 health systems in the U.S., Canada, and Israel. Available data includes: patient demographics, procedures, diagnostics, lab results, medications, physician notes, pathology reports, patient surveys, genetic markers, imaging results, utilization and cost data, social determinants of health, and administrative documentation.

MDClone’s full suite of analytic, synthetic, and exploration tools enable life science organizations to:

  1. Collaborate with a network of global clinicians, researchers, and developers in healthcare in a space with more than 50 million synthetic patient records

  2. View and dynamically engage with granular structured and unstructured EHR and clinical data with unparalleled speed and security

  3. Identify populations of interest, conduct hypothesis testing, and build new models and tools before validating findings on real data for publications, regulatory submissions, or clinical trials

"MDClone develops technologies that unite the most innovative minds in healthcare with the data needed to dramatically improve patient care and outcomes. Our deep understanding of how to derive meaningful insights from health systems data provides us with a unique foundation that we are using to expand into the evolving RWE market. Instead of waiting months for an analysis or working with limited pre-aggregated data, the Connect Platform allows users to work directly at the source to explore, iterate, and ultimately land on transformative information faster than ever before," said Ziv Ofek, Co-Founder & CEO of MDClone.

To find out more about MDClone for life sciences, visit www.mdclone.com/life-sciences.

About MDClone

MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout the healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel.

About The Global Network

The Global Network is a member-driven collaborative, empowering the largest and most innovative healthcare organizations to work together to perform research and improve operational and patient outcomes faster. Member sites can invite collaborators to explore synthetic data within a secure, controlled, collaborative environment. The Global Network currently has more than 15 member sites around the world. Powered by MDClone, the network connects healthcare organizations to life sciences to facilitate partnership, research, and healthcare advancement in an unparalleled networking model.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220509006212/en/


Erin Giegling
VP of Marketing
Email: erin.giegling@mdclone.com